financetom
Business
financetom
/
Business
/
Madrigal Pharmaceuticals Insider Sold Shares Worth $1,551,490, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Madrigal Pharmaceuticals Insider Sold Shares Worth $1,551,490, According to a Recent SEC Filing
Sep 12, 2024 2:16 AM

03:06 AM EDT, 09/12/2024 (MT Newswires) -- William John Sibold, Director, President and Chief Executive Officer, on September 09, 2024, sold 6,363 shares in Madrigal Pharmaceuticals ( MDGL ) for $1,551,490. Following the Form 4 filing with the SEC, Sibold has control over a total of 55,887 shares of the company, with 55,887 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1157601/000095017024105650/xslF345X05/ownership.xml

Price: 234.90, Change: +1.90, Percent Change: +0.82

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Oilfield services firm SLB names new chief strategy, performance officer
Oilfield services firm SLB names new chief strategy, performance officer
Feb 14, 2025
DENVER, Feb 14 (Reuters) - Oilfield services provider SLB has named new chief strategy and performance officers, according to a company memo seen by Reuters, the latest steps in a larger reorganization of its global structure. Aparna Raman has been appointed chief strategy and marketing officer, the memo said, effective March 1. Raman was most recently president of reservoir performance....
Informatica Leaves More Questions Than Answers After Q4, Deutsche Bank Says
Informatica Leaves More Questions Than Answers After Q4, Deutsche Bank Says
Feb 14, 2025
11:00 AM EST, 02/14/2025 (MT Newswires) -- Informatica's ( INFA ) disappointing Q4 results have left more questions than answers as the company saw greater than anticipated churn, Deutsche Bank said in a note Friday. Management attributed the unforeseen churn to execution and operational failures which it believes are within its control to remediate, the report said. That said, it...
Sweeping US energy department layoffs hit nuclear security, loans office, sources say
Sweeping US energy department layoffs hit nuclear security, loans office, sources say
Feb 14, 2025
WASHINGTON (Reuters) - The administration of Donald Trump has laid off about 1,200 to 2,000 workers at the Department of Energy, including employees at the nuclear security administration and the loans office, two sources familiar with the matter said on Friday. Democratic lawmakers also said the layoffs include workers at national labs and hydroelectric plants, and Cold War legacy nuclear...
West Pharmaceutical Services Stock Touches 'Attractive Entry Point,' Deutsche Bank Says
West Pharmaceutical Services Stock Touches 'Attractive Entry Point,' Deutsche Bank Says
Feb 14, 2025
11:03 AM EST, 02/14/2025 (MT Newswires) -- West Pharmaceutical Services ( WST ) has a solid position in the injectable-drug containment market with sticky recurring revenue, and the stock price has dropped to an attractive entry point after underwhelming Q4 results and 2025 guidance, Deutsche Bank said Friday in a note. The stock is currently trading close to pre-pandemic levels...
Copyright 2023-2026 - www.financetom.com All Rights Reserved